Navigation Links
Study may aid efforts to prevent uncontrolled cell division in cancer
Date:5/28/2009

Researchers from the Ludwig Institute for Cancer Research at the University of California, San Diego School of Medicine have uncovered a remarkable property of the contractile ring, a structure required for cell division. Understanding how the contractile ring works to divide the cell may facilitate development of therapies to prevent uncontrolled cell division in cancer.

The researchers show that even though both cell volume and the length of the contractile ring are reduced during successive rounds of embryonic cell division the duration or timing of cell division remains the same. Their study will be published in the May 29 issue of the journal Cell.

"We showed that contractile rings constrict at a constant rate that is proportional to the initial size of the cell, so that rings in larger cells constrict proportionally faster than rings in smaller cells," said Karen Oegema, PhD, associate professor at the Ludwig Institute and the Department of Cellular and Molecular Medicine at UC San Diego School of Medicine and the Moores UCSD Cancer Center. "Because of this property, the time required to complete cell division remains the same during embryogenesis, even as cells get smaller."

During their early development, embryos are progressively partitioned into smaller and smaller cells by successive rounds of cell division. The division of one cell into two is accomplished by the contractile ring, which is assembled from two protein filament types also used in muscle. During cell division, the genome is replicated and the two copies are separated to opposite sides of the cell. A contractile ring forms a belt around the cell middle; constriction or closure of this ring "tightens the belt," pinching the mother cell into two daughter cells.

In early embryogenesis, cell volume and the length of the contractile ring around the cell middle are reduced at each successive round of cell division. By contrast, the dimension of the chromosomes which carry the genetic material that is segregated to the daughter cells remains constant. The discovery that contractile rings constrict at a constant rate, proportionate to the initial cell size, opens the door to further studies of the mechanism.

"Further studies of the contractile ring could ultimately lead to improved therapies for cancer," said first author Ana Carvalho, PhD. "Understanding the cellular machinery required for cell division may teach us how to prevent the uncontrolled cell division that occurs in cancer."


'/>"/>

Contact: Steve Benowitz
sbenowitz@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Related biology news :

1. The coming of biofuels: Study shows reducing gasoline emissions will benefit human health
2. Yale study: Most polluted ecosystems recoverable
3. Study shows CGM devices also benefit people with type 1 diabetes
4. Bolivian rainforest study suggests feeding behavior in monkeys and humans have ancient, shared roots
5. University of Florida study provides insight into evolution of first flowers
6. Study finds genetic links to age of first menstrual period and menopause
7. Study finds link between individual stress and adolescent obesity
8. WWF study says climate change could displace millions in Asias Coral Triangle
9. Study reveals conflict between doctors, midwives over homebirth
10. UNC study identifies genetic cause of most common form of breast cancer
11. Comprehensive genetic study paves way for new blood-pressure medicines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2017)... SAN ANTONIO , Feb. 3, 2017  Texas Biomedical ... Dr. Larry Schlesinger as the Institute,s ... of Texas Biomed effective May 31, 2017. He is currently ... and Director of the Center for Microbial Interface Biology at ... Dr. Schlesinger as the new President and CEO of Texas ...
(Date:2/2/2017)... 2, 2017  EyeLock LLC, a market leader of ... paper " What You Should Know About Biometrics in ... user authenticity is a growing concern. In traditional schemes, ... However, traditional authentication schemes such as username/password suffer from ... authentication offers an elegant solution to the problem of ...
(Date:1/31/2017)... Mass. , Jan. 31, 2017  Spero ... novel therapies for the treatment of bacterial infections, ... set of antibacterial candidates from Pro Bono Bio ... increased prevalence of multi-drug resistant forms of Gram-negative ... Cantab Anti Infectives Ltd, a PBB group company. ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... Feb. 24, 2017 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced its unaudited financial results for the third quarter ... December 31, 2016. Third Quarter of Fiscal ... quarter of fiscal 2017 increased by 18.6% to RMB200.9 ...
(Date:2/24/2017)... -- VWR Corporation (NASDAQ: VWR), the leading global independent provider of ... reported its financial results for the fourth quarter and full ... 4Q16 record quarterly net sales of $1.13 billion, ... 4Q16 EMEA-APAC segment net sales ... Americas net sales increased 2.5%, or down 0.9% on an ...
(Date:2/23/2017)... RAFAEL, Calif., Feb. 23, 2017 ... U.S. dollars, except per share data, unaudited)Three Months Ended ... ChangeTotal BioMarin Revenue $   ...   22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... JOSE, Calif. , Feb. 23, 2017 /PRNewswire/ ... exclusive license for two key immunotherapy technologies from ... first technology provides a method to monitor a ... such as PD-L1 and CTLA-4.  The second license ... if a patient is likely to have an ...
Breaking Biology Technology: